News | June 08, 2024
GSK acquires oligonucleotide drug startup Elsie
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
PICCOLO trial met its primary endpoint of objective response rate (ORR)
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Merck shared updates on the company’s oncology pipeline and focused R&D approach
The HD21 study adds to the body of evidence supporting ADCETRIS as a backbone agent in the treatment of specific lymphomas
Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
Greg was also central to the planning, design, and construction of this facility
Bluecrux's digital supply chain twin technology, Axon, plays a critical role in Sanofi's digital supply chain transformation.
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
Subscribe To Our Newsletter & Stay Updated
